| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/09/2009 | US20090092993 Cellular arrays and methods of detecting and using genetic disorder markers |
| 04/09/2009 | US20090092992 Novel human dickkopf-related protein and nucleic molecules and uses therefor |
| 04/09/2009 | US20090092986 Nucleotide derivative for use in sequence determination of nucleic acid molecule; conjugate comprising fluorescent dye such as a xanthene dye, a rhodamine dye or a fluorescein; electrophoretic mobility; RNA or DNA sequencing |
| 04/09/2009 | US20090092981 Tetrahydropyran nucleic acid analogs |
| 04/09/2009 | US20090092977 Mass spectrometric methods for detecting mutations in a target nucleic acid |
| 04/09/2009 | US20090092975 Selectable marker |
| 04/09/2009 | US20090092963 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
| 04/09/2009 | US20090092962 Oligonucleotide primer that can specifically hybridize with any nucleotide sequence constructed based on the nucleotide sequence of RNA polymerase of the SARS coronavirus; kits |
| 04/09/2009 | US20090092703 Phytase-Expressing Transgenic Plants |
| 04/09/2009 | US20090092698 Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes |
| 04/09/2009 | US20090092659 containing protonated/acidified nucleic acids that are bactericidal; wound sealant, surgical drape , skin substitute |
| 04/09/2009 | US20090092638 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
| 04/09/2009 | US20090092634 Chicken Virus Vaccine and Diagnostic |
| 04/09/2009 | US20090092627 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 04/09/2009 | US20090092623 Promoter |
| 04/09/2009 | US20090092616 ZNF206: A Novel Regulator of Embryonic Stem Cell Self-renewal and Pluripotency |
| 04/09/2009 | US20090092613 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 04/09/2009 | US20090092612 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 04/09/2009 | US20090092608 Human Tumor Necrosis Factor Receptor-Like 2 |
| 04/09/2009 | US20090092606 Antibacterial treatments |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092601 HUMANIZED ANTI-LT-beta-R ANTIBODIES |
| 04/09/2009 | US20090092597 Mammalian cell surface antigens; related reagents |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |
| 04/09/2009 | US20090092592 Methionyl tRNA Synthetase Polynucleotides |
| 04/09/2009 | US20090092589 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/09/2009 | US20090092588 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including parkinson's disease |
| 04/09/2009 | US20090092582 Compositions and methods for modifying properties of biologically active polypeptides |
| 04/09/2009 | US20090092581 Interferons of rhesus and cynomolgus origin and uses thereof |
| 04/09/2009 | US20090092579 Novel method for down-regulation of amyloid |
| 04/09/2009 | US20090092578 Methods of selecting and producing modified toxins, conjugates containing modified toxins, and uses thereof |
| 04/09/2009 | US20090092557 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/09/2009 | DE19543553B4 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 04/09/2009 | DE10208877B4 Verwendung eines Streptavidin- Bindungspeptides Using a streptavidin-binding peptide |
| 04/09/2009 | DE102007048134A1 Cloning, integration and expression of a gene cluster comprises using gene cassettes comprising sequences that mediate the transfer, integration and expression of a flanked nucleic acid |
| 04/09/2009 | DE102007041476A1 Aptamere, die an ein an der Hämostase beteiligtes Zielmolekül binden Aptamers that bind to a party to the hemostasis target molecule |
| 04/09/2009 | CA2738070A1 Novel compounds for the treatment or alleviation of edema, and methods for their use |
| 04/09/2009 | CA2715080A1 Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
| 04/09/2009 | CA2702028A1 Tripartite rnai constructs |
| 04/09/2009 | CA2701895A1 Short rna antagonist compounds for the modulation of hif1alpha |
| 04/09/2009 | CA2701846A1 Extracellular targets for alzheimer's disease |
| 04/09/2009 | CA2701845A1 Novel sirna structures |
| 04/09/2009 | CA2701796A1 Laboratory-selected colonies of western corn rootworm with increased tolerance to maize containing event das-59122-7 and methods of use |
| 04/09/2009 | CA2701775A1 A novel bacteriocin from a new streptomyces species |
| 04/09/2009 | CA2701686A1 Methods of treating cancer using notch pathway inhibitors |
| 04/09/2009 | CA2701639A1 Modulating gene expression with agrna and gapmers targeting antisense transcripts |
| 04/09/2009 | CA2701636A1 Methods for transferring molecular substances into plant cells |
| 04/09/2009 | CA2701561A1 Widespread gene delivery to motor neurons using peripheral injection of aav vectors |
| 04/09/2009 | CA2701547A1 Micromirs |
| 04/09/2009 | CA2701542A1 Attenuated invasive e. coli strains and applications thereof as intracellular vector for therapeutic molecule |
| 04/09/2009 | CA2701274A1 Lipopeptides for delivery of nucleic acids |
| 04/09/2009 | CA2701215A1 Articular cartilage gene therapy with recombinant vector encoding bmp-7 |
| 04/09/2009 | CA2701130A1 Peroxisome biogenesis factor protein (pex) disruptions for altering the content of polyunsaturated fatty acids and the total lipid content in oleaginous eukaryotic organisms |
| 04/09/2009 | CA2701128A1 Antisense modulation of fibroblast growth factor receptor 4 expression |
| 04/09/2009 | CA2701117A1 Xylanases, nucleic acids encoding them and methods for making and using them |
| 04/09/2009 | CA2701094A1 Optimized strains of yarrowia lipolytica for high eicosapentaenoic acid production |
| 04/09/2009 | CA2700953A1 Increasing erythropoietin using nucleic acids hybridizable to micro-rna and precursors thereof |
| 04/09/2009 | CA2700860A1 Human antibodies that bind mesothelin, and uses thereof |
| 04/09/2009 | CA2700826A1 Bacterium capable of fermenting glucose, mannose and xylose simultaneously, and method for production of bioethanol using the bacterium |
| 04/09/2009 | CA2700688A1 Genetic markers for horned and polled cattle and related methods |
| 04/09/2009 | CA2700380A1 Compositions and methods for altering alpha- and beta-tocotrienol content using multiple transgenes |
| 04/09/2009 | CA2700011A1 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 04/09/2009 | CA2699601A1 Nlrr-1 antagonists and uses thereof |
| 04/09/2009 | CA2699451A1 Bacteriophage with enhanced lytic activity |
| 04/09/2009 | CA2698627A1 System for capturing and modifying large pieces of genomic dna and constructing organisms with synthetic chloroplasts |
| 04/08/2009 | EP2045604A1 Method for examining WT1-related disease |
| 04/08/2009 | EP2045337A1 Process for synthesizing nucleic acid |
| 04/08/2009 | EP2045336A2 Characterisation of gene function using double stranded RNA inhibition |
| 04/08/2009 | EP2045331A1 Attenuated invasive E. coli strains and their applications as an intracellular vector for therapeutic molecules |
| 04/08/2009 | EP2045330A1 Novel expression vector with enhanced gene expression capacity and method for using the same |
| 04/08/2009 | EP2045329A1 Flagellin mutant vaccine |
| 04/08/2009 | EP2045328A1 Peptide and nucleotide sequences of anisakis spp., antibodies that recognise said sequences and uses of same |
| 04/08/2009 | EP2045327A2 Expression enhancing intron sequences |
| 04/08/2009 | EP2045326A1 Method for identifying the interaction partner of an active agent |
| 04/08/2009 | EP2045325A1 Drug-phosphorylating enzyme |
| 04/08/2009 | EP2045324A1 Method for production of n36-binding peptide |
| 04/08/2009 | EP2045323A1 Linear expression constructs for production of influenza virus particles |
| 04/08/2009 | EP2045322A1 Double-muscling in mammals |
| 04/08/2009 | EP2045321A2 Serine proteases with altered sensitivity to activity-modulating substances |
| 04/08/2009 | EP2045267A2 Humanized antibodies that recognize beta amyloid peptide |
| 04/08/2009 | EP2045262A1 Insecticidal proteins from bacillus thuringiensis |
| 04/08/2009 | EP2045261A1 Chlamydia pneumoniae antigenic polypeptides |
| 04/08/2009 | EP2045260A1 Replication deficient RNA viruses as vaccines |
| 04/08/2009 | EP2045259A1 Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase |
| 04/08/2009 | EP2045005A2 Devices and methods for carrying out chemical reactions using photogenerated reagents |
| 04/08/2009 | EP2044950A2 Attenuated VIF DNA immunization cassettes for genetic vaccines |
| 04/08/2009 | EP2044948A1 Methods and compositions concerning poxviruses and cancer |
| 04/08/2009 | EP2044839A2 Production of humanized antibodies in transgenic animals |
| 04/08/2009 | EP2044402A2 Assay particle concentration and imaging apparatus and method |
| 04/08/2009 | EP2044216A2 Prostate specific transcripts and the use thereof for prostate cancer therapeutics and diagnostics |
| 04/08/2009 | EP2044207A1 Protein targeting to lipid bodies |
| 04/08/2009 | EP2044206A2 Generation of plants with improved pathogen resistance |
| 04/08/2009 | EP2044205A1 Method for generation of mutants in plants |
| 04/08/2009 | EP2044204A2 Plant expression constructs and methods of utilizing same |
| 04/08/2009 | EP2044203A2 Methods for increasing expression of genes in a fungal cell |
| 04/08/2009 | EP2044202A2 Kex2 cleavage regions of recombinant fusion proteins |
| 04/08/2009 | EP2044201A1 A mutant histidine kinase that confers spontaneous nodulation in plants |
| 04/08/2009 | EP2044200A1 Uses and compositions comprising mirnas |
| 04/08/2009 | EP2044122A2 Antagonist antibody against epha2 for the treatment of cancer |
| 04/08/2009 | EP2044118A2 Il-17 and il-23 antagonists and methods of using the same |